178 results on '"Hori, Hikaru"'
Search Results
2. Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project
3. Effect of the guideline education program on anticholinergic and benzodiazepine use in outpatients with schizophrenia and major depressive disorder: The effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE) project
4. Appropriate duration of antidepressant medications for prevention of depressive relapse and the impact of life stage
5. Cognitive improvement in patients with major depressive disorder after personalised multi domain training in the CERT-D study
6. Bipolar disorder and Lewy body dementia: case report and literature review
7. The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study
8. Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study
9. The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the “Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)” project
10. The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project
11. Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study
12. No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial
13. Emotional Blunting in Depression in the PREDDICT Clinical Trial: Inflammation-Stratified Augmentation of Vortioxetine With Celecoxib
14. Association between organizational justice and serious psychological distress among hospital nursing staff during the COVID‐19 pandemic: A cross‐sectional study.
15. Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta‐analysis.
16. Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study
17. Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study
18. Benzodiazepine withdrawal catatonia after discontinuing midazolam in young patient with intellectual developmental disorder: A case report
19. Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta‐analysis
20. Effects of Exercise on Functional Recovery in Patients with Bipolar Depression: A Study Protocol for a Randomized Controlled Trial
21. Evaluation of Changes in Anxiety, Depression, Social Behavior, and Oxytocin mRNA Levels in Adults after Adolescent Interventions in Maternal-separated Mice
22. Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics
23. Change of prescription for patients with schizophrenia or major depressive disorder during admission: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education psychiatric treatment project
24. Management of unspecified anxiety disorder: Expert consensus
25. Management of unspecified anxiety disorder: Expert consensus
26. Clinical practice for unspecified anxiety disorder in primary care.
27. Successful treatment of switching from benzodiazepine to orexin receptor antagonists improves cognitive function in psychiatric disorders: four case reports
28. Satisfaction with web‐based courses on clinical practice guidelines for psychiatrists: Findings from the “Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)” project
29. Development of an individual fitness score ( IFS ) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders
30. Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score‐matched analysis
31. Corrigendum to ‘No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial’ [European Neuropsychopharmacology 53 (2021) 34–46]
32. Motor Functional Characteristics in Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorders: A Systematic Review
33. Development of individual fitness score for conformity of prescriptions to the “Guidelines For Pharmacological Therapy of Schizophrenia”
34. Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia
35. Mood Stabilizers and Antipsychotics for Acute Mania: Systematic Review and Meta-Analysis of Augmentation Therapy vs Monotherapy From the Perspective of Time to the Onset of Treatment Effects
36. Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission
37. Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study
38. Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
39. Development of individual fitness score for conformity of prescriptions to the “Guidelines For Pharmacological Therapy of Schizophrenia”
40. Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission
41. Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
42. Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry
43. Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the “Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)” project
44. A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project
45. Motor Functional Characteristics in Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorders: A Systematic Review [Corrigendum]
46. Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders.
47. Satisfaction with web‐based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project.
48. A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project
49. Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry
50. Pre-treatment plasma cytokine levels as potential predictors of short-term remission of depression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.